H.C. Wainwright downgraded Timber Pharmaceuticals to Neutral from Buy without a price target after the company entered into a definitive agreement to merge with LEO Pharma for a total transaction value of $36M. The firm says it can’t be certain of the outcome with respect to the contingent value rights. It does not anticipate any rival bids.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on TMBR:
